The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Abstract
Dihydrotestosterone (DHT) is the primary metabolite of testosterone in the prostate and skin. Testosterone is converted to DHT by 5alpha-reductase, which exists in two isoenzyme forms (types 1 and 2). DHT is associated with development of benign prostatic hyperplasia (BPH), and reduction in its level with 5alpha-reductase inhibitors improves the symptoms associated with BPH and reduces the risk of acute urinary retention and prostate surgery. A selective inhibitor of the type 2 isoenzyme (finasteride) has been shown to decrease serum DHT by about 70%. We hypothesized that inhibition of both isoenzymes with the dual inhibitor dutasteride would more effectively suppress serum DHT levels than selective inhibition of only the type 2 isoenzyme. A total of 399 patients with BPH were randomized to receive once-daily dosing for 24 wk of dutasteride (0.01, 0.05, 0.5, 2.5, or 5.0 mg), 5 mg finasteride, or placebo. The mean percent decrease in DHT was 98.4 +/- 1.2% with 5.0 mg dutasteride and 94.7 +/- 3.3% with 0.5 mg dutasteride, significantly lower (P < 0.001) and with less variability than the 70.8 +/- 18.3% suppression observed with 5 mg finasteride. Mean testosterone levels increased but remained in the normal range for all treatment groups. Dutasteride appeared to be well tolerated with an adverse event profile similar to placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism
Imperato-McGinley, J., Guerrero, L., Gautier, T., & Peterson, R. E. (1974) · Science · doi:10.1126/science.186.4170.1213 · Cited by 1,258
McConnell, J. D., Bruskewitz, R., Walsh, P., Andriole, G., Lieber, M., Holtgrewe, H. L., Albertsen, P., Roehrborn, C. G., Nickel, J. C., Wang, D. Z., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380901 · Cited by 1,120
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Finasteride in the treatment of men with androgenetic alopecia
Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., Price, V. H., Van Neste, D., Roberts, J. L., Hordinsky, M., et al. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70007-6 · Cited by 772
Roehrborn, C. G., Boyle, P., Nickel, J. C., Hoefner, K., & Andriole, G. (2002) · Urology · doi:10.1016/s0090-4295(02)01905-2 · Cited by 729
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
Thigpen, A. E., Silver, R. I., Guileyardo, J. M., Casey, M. L., McConnell, J. D., & Russell, D. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116665 · Cited by 727
Walsh, P. C., Madden, J. D., Harrod, M. J., Goldstein, J. L., MacDonald, P. C., & Wilson, J. D. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410312911806 · Cited by 631
Steroid 5α-reductase 2 deficiency
Mendonca, B. B., Batista, R. L., Domenice, S., Costa, E. M. F., Arnhold, I. J. P., Russell, D. W., & Wilson, J. D. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.05.020 · Cited by 546
Sawaya, M. E., & Price, V. H. (1997) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12335779 · Cited by 505
Molecular genetics of steroid 5 alpha-reductase 2 deficiency
Thigpen, A. E., Davis, D. L., Milatovich, A., Mendonca, B. B., Imperato-McGinley, J., Griffin, J. E., Francke, U., Wilson, J. D., & Russell, D. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115954 · Cited by 422
Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase.
Jenkins, E. P., Andersson, S., Imperato-McGinley, J., Wilson, J. D., & Russell, D. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115574 · Cited by 395
McConnell, J. D. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.3.505 · Cited by 325
Thiboutot, D., Harris, G., Iles, V., Cimis, G., Gilliland, K., & Hagari, S. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12317162 · Cited by 221
Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency
Imperato‐McGinley, J., Gautier, T., Zirinsky, K., Hom, T., Palomo, O., Stein, E. A., Vaughan, E. D., Markísz, J. A., de Arellano, E. R., & Kazam, E. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.4.1400866 · Cited by 184
GORMLEY, G. J., STONER, E., RITTMASTER, R. S., GREGG, H., THOMPSON, D. L., LASSETER, K. C., VLASSES, P. H., & STEIN, E. A. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-1136 · Cited by 162
Emerging Issues in Androgen Replacement Therapy1
Bhasin, S., & Bremner, W. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3640 · Cited by 160
Thigpen, A. E., Cala, K. M., & Russell, D. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85349-8 · Cited by 152
Unique Preclinical Characteristics of GG745, A Potent Dual Inhibitor of 5AR
Bramson, H. N., Hermann, D. J., Batchelor, K. W., Lee, F. W., James, M. K., & Frye, S. V. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36949-6 · Cited by 152
Self-citationRole of dihydrotestosterone in androgen action
Wilson, J. D. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(1996)6+<88::aid-pros17>3.0.co;2-n · Cited by 83
Span, P. N., Völler, M., SMALS, A. G. H., Sweep, F. C. G. J., Schalken, J. A., Feneley, M. R., & Kirby, R. S. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)62141-4 · Cited by 82
Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men
Rittmaster, R. S., Lemay, A., Zwicker, H., Capizzi, T. P., Winch, S., Moore, E., & Gormley, G. J. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.2.1322427 · Cited by 78
Rittmaster, R. S. (1998) · PubMed · Cited by 55
Hudson, P. B., Boake, R., Trachtenberg, J., Romas, N. A., Rosenblatt, S., Narayan, P. A., Geller, J., Lieber, M. M., ELHILALI, M. M., Norman, R., et al. (1999) · Urology · doi:10.1016/s0090-4295(98)00666-9 · Cited by 54
Messenger RNA Expression of Steroidogenesis Enzyme Subtypes in the Human Pilosebaceous Unit
Courchay, G., Boyera, N., Bernard, B. A., & Mahé, Y. F. (2009) · Skin Pharmacology · doi:10.1159/000211412 · Cited by 53
Matsumoto, A. M., Tenover, J. L., McClung, M. R., Mobley, D. F., Geller, J., Sullivan, M. J., Grayhack, J. T., Wessells, H., Kadmon, D., Flanagan, M. J., et al. (2002) · PubMed · Cited by 52
Gisleskog, P. O., Hermann, D. J., Hammarlund‐Udenaes, M., & Karlsson, M. O. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00843.x · Cited by 48
Self-citationPelletier, G., LUU-THE, V., HUANG, X.-F., Lapointe, H., & Labrie, F. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62961-6 · Cited by 48
Habib, F. K., Ross, M., Bayne, C. W., Grigor, K. M., Buck, A. C., Bollina, P. R., & Chapman, K. E. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560509 · Cited by 46
Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5α-reductase inhibitor
Schepper, P. J. D., Imperato‐McGinley, J., Hecken, A. V., Lepeleire, I. D., Buntinx, A., Carlin, J. R., Gressi, M. H., & Stoner, E. (1991) · Steroids · doi:10.1016/0039-128x(91)90003-e · Cited by 28
Schwartz, J. I., Hecken, A. V., Schepper, P. J. D., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768856 · Cited by 21
Cited by
Pharmacology of anabolic steroids
Kicman, A. T. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.165 · Cited by 580
Nestor, M. S., Ablon, G., Gade, A., Han, H., & Fischer, D. L. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14537 · Cited by 410
Roehrborn, C. G., Siami, P., Barkin, J., Damião, R., Major-Walker, K., Morrill, B., Montorsi, F., & CombAT Study Group (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.084 · Cited by 356
Self-citationDihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer
Chang, K.-H., Li, R., Papari-Zareei, M., Watumull, L., Zhao, Y. D., Auchus, R. J., & Sharifi, N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107898108 · Cited by 346
The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
Azzouni, F., Godoy, A., Li, Y., & Mohler, J. (2012) · Advances in Urology · doi:10.1155/2012/530121 · Cited by 333
Metadata
- Authors
- Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-05
- Volume
- 89
- Issue
- 5
- Pages
- 2179-2184
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2020105514
- Cited by
- 467
- References
- 30
- FWCI
- 22.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.